Skip to content
Amkay Products logo

Amkay Products

544169 BSE
₹53.50

Close ·

P/E
25.48
View as Markdown
MCP
Close 4 Nov 2026 ₹53.50 +5.50 +11.5% 1Y
Start ₹48.00

Key Fundamentals

SMEHealthcare Equipment & SuppliesHealthcare

Price-based figures at the close · TTM

ROCE
12.00%
Debt to Equity
0.15
EPS (TTM)
₹2.10
Book Value
₹30.47
Market Cap
—
P/E (TTM)
25.48
P/B
1.76
ROE
8.09%
Dividend Yield
0.00%
EBITDA
₹4.50 Cr
52W High
₹81.99
52W Low
₹43.00

Key Insights

No strengths listed

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 0.68% over past five years.
  • Company has a low return on equity of 11.7% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1225
OscillatorsStrong Bullish225
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
40.13
Neutral
MACD (12,26,9)
−1.38
Bearish
SMA (50)
56.65
Bearish
SMA (200)
57.07
Bearish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+0.68%
3Y+14.69%
1Y+9.48%

Net profit

Net profit growth by window
5Y−4.31%
3Y+14.22%
1Y−30.84%

Operating cash flow

Operating cash flow growth by window
5YZero base
3Y+390.49%
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
5Y−1.89 pp
3Y−1.36 pp
1Y−1.60 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2020₹26.41 Cr
Mar 2021₹40.63 Cr
Mar 2022₹36.47 Cr
Mar 2023₹27.86 Cr
Mar 2024₹31.07 Cr
Mar 2025₹38.39 Cr
Mar 2026₹42.03 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020₹0.48 Cr
Mar 2021₹2.88 Cr
Mar 2022₹1.47 Cr
Mar 2023₹1.55 Cr
Mar 2024₹2.63 Cr
Mar 2025₹3.34 Cr
Mar 2026₹2.31 Cr

Half-yearly Results

₹ Cr
544169 half-yearly results, ₹ crore
Particulars Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
14.37
16.69
17.84
20.55
23.01
19.02
Expenses
12.58
15.15
15.45
18.81
20.04
18.15
Operating Profit
1.79
1.54
2.39
1.74
2.97
0.87
OPM %
12.46%
9.23%
13.4%
8.47%
12.91%
4.57%
Other Income
0.48
0.76
0.73
0.59
0.39
0.28
Interest
0.24
0.28
0.18
0.14
0.25
0.18
Depreciation
0.26
0.3
0.34
0.49
0.43
0.46
PBT
1.77
1.72
2.6
1.7
2.68
0.51
Tax %
26.55%
23.26%
30%
10.59%
26.87%
33.33%
Net Profit
1.3
1.33
1.83
1.51
1.97
0.34
EPS (₹)
2.04
2.09
2.11
1.74
2.28
0.39

Profit & Loss

₹ Cr
544169 profit and loss, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
26.41
40.63
36.47
27.86
31.07
38.39
42.03
Expenses
24.82
36.14
33.78
24.93
27.74
34.26
38.18
Operating Profit
1.59
4.49
2.69
2.93
3.33
4.13
3.85
OPM %
6.02%
11.05%
7.38%
10.52%
10.72%
10.76%
9.16%
Other Income
0.04
0.1
0.29
0.46
1.25
1.32
0.67
Interest
0.47
0.24
0.41
0.47
0.52
0.32
0.43
Depreciation
0.52
0.51
0.54
0.69
0.56
0.83
0.88
PBT
0.64
3.84
2.03
2.23
3.5
4.3
3.21
Tax %
25%
25%
28.08%
30.49%
24.86%
22.33%
27.73%
Net Profit
0.48
2.88
1.47
1.55
2.63
3.34
2.31
EPS (₹)
8
48
24.5
25.83
4.13
3.86
2.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
544169 balance sheet, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.28
0.28
0.28
0.28
6.36
8.66
8.66
Reserves
2.42
5.67
5.93
7.1
3.64
15.41
17.72
Borrowings
1.62
0.42
4.33
4.7
5.47
2.64
3.92
Other Liabilities
2.55
7.69
5.26
2.9
2.47
3.18
3.01
Total Liabilities
6.87
14.06
15.8
14.98
17.94
29.89
33.31
Fixed Assets
0
0
3.91
2.4
2.58
4.14
4.27
CWIP
0
0
0
0
0
0.12
0
Investments
0
0.4
2.79
3.62
2.57
6.85
6.5
Other Assets
6.87
13.66
9.1
8.96
12.79
18.78
22.54
Total Assets
6.87
14.06
15.8
14.98
17.94
29.89
33.31

Cash Flow

₹ Cr
544169 cash flow, annual, ₹ crore
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
−0.25
0.01
−0.66
−0.31
1.18
Investing
0
0
−3.07
−0.34
0.48
−5.84
−0.4
Financing
0
0
2.59
0.31
0.24
7.58
0.86
Net Cash Flow
0
0
−0.72
−0.01
0.06
1.43
1.64
Free Cash Flow
0
0
−2.4
−0.01
−1.82
−3.04
−0.08
CFO/EBITDA
0
0
10
32
7
17
54

Ratios

544169 financial ratios, annual
Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
31.23
40.43
36.33
48.47
46.87
57.14
42.81
Inventory Days
4.54
4.18
28.03
46.61
92.57
113
125
Days Payable
41.76
82.57
64.42
44.46
33.99
36.44
28.98
Cash Conversion Cycle
−5.98
−37.96
−0.06
50.62
105
134
139
Working Capital Days
10.78
−8.62
21.12
54.11
56.15
104
96.4
ROCE %
—
76.33%
28.86%
20.87%
22.36%
16.88%
12.03%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Amkay Products insights

54 extracted metrics across FY20–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.44%
  • Public 24.04%
  • Others 2.52%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Amkay Products

What does Amkay Products Ltd do?
Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products
Where is Amkay Products Ltd (AMKAY) listed?
Amkay Products Ltd trades under code 544169 on the BSE.
Which sector does Amkay Products Ltd belong to?
Amkay Products Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the PE ratio of Amkay Products Ltd?
Amkay Products Ltd trades at a PE ratio of 25.48 as of 4 Nov 2026, on earnings per share of ₹2.1, against a book value of ₹30.47 per share.
What is the 52-week high and low of Amkay Products Ltd?
Over the last 52 weeks Amkay Products Ltd has traded between ₹43 and ₹81.99 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Amkay Products Ltd?
Amkay Products Ltd reported a return on equity of 8.09%. Its debt-to-equity ratio is 0.15.

Company Information

Incorporated in 2007, Amkay Products Ltd manufactures personalized healthcare products

Website amkayproducts.com
Listed 8 May 2024
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544169.md for Amkay Products Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Healthcare Equipment stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month